News Chart HANDOK Inc.

Equities

A002390

KR7002390003

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-06-13 EDT			5-day change	1st Jan Change
14,870 ^KRW	-0.60%		-3.38%	+3.99%

05-24	Biocon Ties Up with Handok to Market Anti-Diabetic Drug Liraglutide in South Korea	MT
05-24	Biocon Limited Signs Exclusive Licensing and Supply Deal for the Commercialization of Liraglutide in South Korea with Handok Inc	CI

9f6884cc5808ef9e42fb3.9Mg_2ONeF2Q853EG3O8_h2MFXJoWE_jso_rpQOoJ940.w65drJUMdApeiQVHkdYN3i5sHdd_PoGUzMKuDoQ-r_W1p1a8rCp9PgrXSQ~a9f093b520edda83202d97464a3bbe08